US · Healthcare · Medical Care Facilities
EPS came in at 7.59 against a street estimate of 7.57 — a beat of 0.3%.
Analysts rate HCA Healthcare, Inc. a buy (15 buy, 9 hold, 2 sell out of 26) with an average price target of $460.59.
| Fund | Stake |
|---|---|
| BlackRock Inc | 6.01% |
| Vanguard Capital Management, LLC | 4.68% |
| Sanders Capital, LLC | 4.08% |
| State Street Corp | 3.45% |
| Arnhold & S. Bleichroeder Advisers, LLC | 3.04% |
| Wellington Management Company LLP | 2.17% |
| Geode Capital Management, LLC | 1.69% |
| Vanguard Portfolio Management, LLC | 1.25% |
| Document | Date |
|---|---|
| Company announcement · Q3 2026 HCA HEALTHCARE, INC. - 8-K SUMMARY HEADLINE NUMBERS • Commercial paper program maximum capacity increased from $4.0 billion to $8.0 billion • Increa | 2026-07-29 |
| Quarterly report · Q2 2026 HCA HEALTHCARE, INC. - 10-Q SUMMARY For Quarter and Six Months Ended June 30, 2026 --- HEADLINE NUMBERS • Q2 2026 Revenue: $20,230 million vs. Q2 2 | 2026-07-28 |
| Results announced · Q3 2026 HCA HEALTHCARE Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Revenues: $20.230 billion in Q2 2026, up 8.7% vs Q2 2025 ($18.605 billion) • Net income at | 2026-07-24 |
| Results announced · Q3 2026 HCA HEALTHCARE Q2 2026 PRELIMINARY RESULTS SUMMARY HEADLINE NUMBERS • Q2 2026 Revenues: $20.230 billion vs. $18.605 billion in Q2 2025 (+8.7% year-o | 2026-07-14 |
| Board / officer change · Q2 2026 HCA HEALTHCARE, INC. – 8-K SUMMARY HEADLINE NUMBERS • No financial results, revenue figures, or quantitative metrics disclosed in this filing • Docum | 2026-06-18 |
| Quarterly report · Q1 2026 HCA HEALTHCARE, INC. — FORM 10-Q SUMMARY Quarter Ended March 31, 2026 --- HEADLINE NUMBERS • Revenues: $19,109 million (Q1 2026) vs. $18,321 millio | 2026-04-29 |
| Proxy statement · Q2 2026 HCA HEALTHCARE PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect nine director nominees (majority vote required in unconte | 2026-03-13 |
| Annual report FY2025 HCA HEALTHCARE, INC. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total revenues (2025): $75.6 billion, up from $70.6 billion in 2024 (7.1 | 2026-02-10 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.78 / share ex-date Sep 16, 2026 · pay Sep 30, 2026 | 2026-09-16 |
| Dividend | $0.78 / share ex-date Jun 16, 2026 · pay Jun 30, 2026 | 2026-06-16 |
| Dividend | $0.78 / share ex-date Mar 17, 2026 · pay Mar 31, 2026 | 2026-03-17 |
| Dividend | $0.72 / share ex-date Dec 15, 2025 · pay Dec 29, 2025 | 2025-12-15 |
| Dividend | $0.72 / share ex-date Sep 16, 2025 · pay Sep 30, 2025 | 2025-09-16 |
| Announcement | Date |
|---|---|
| Q2 2026 results with updated guidance and key assumptions HCA Healthcare reported Q2 2026 results with mixed performance. Revenues grew 8.7% to $20.2 billion, and diluted EPS increased 11.6% to $7.62. However, net income growth was modest at only 2 | 2026-07-24 |
| Previews Q2 2026 results and revises full year 2026 guidance HCA Healthcare reported Q2 2026 preliminary results showing revenue growth to $20.23 billion (vs. $18.61 billion YoY) and net income of $1.70 billion ($7.62 per share vs. $6.83 YoY). However | 2026-07-14 |
| Fourth quarter 2025 results reported and 2026 guidance provided HCA Healthcare reported strong fourth-quarter 2025 results with significant growth across key metrics. Revenues grew 6.7% to $19.513 billion, while net income jumped 30.6% to $1.878 billion. | 2026-01-27 |
| Raises 2025 full-year revenue and profit guidance on strong Q3 results HCA Healthcare reported strong third quarter 2025 results with significant growth across key metrics. Revenues increased 9.6% to $19.161 billion, while net income surged 29.4% to $1.643 bill | 2025-10-24 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for HCA Healthcare, Inc. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.